Literature DB >> 11780596

Psychopharmacological treatment of patients with HIV and AIDS.

Stephen J Ferrando1, Khakasa Wapenyi.   

Abstract

Psychopharmacological treatment of patients with HIV/AIDS is an important aspect of managing distress and enhancing quality of life. This article reviews the psychopharmacological management of depression, anxiety, mania, and psychosis in the context of HIV/AIDS, with a discussion of psychotropic-antiretroviral drug interactions. While psychopharmacological management of HIV/AIDS patients may be complex, there is a substantial amount of clinical and research information describing both conventional and novel approaches that are safe and effective.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11780596     DOI： 10.1023/a:1012840717735

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN： 0033-2720


  57 in total

1.  Psychostimulant response in AIDS-related complex patients.

Authors:  V F Holmes; F Fernandez; J K Levy
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

2.  Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.

Authors:  J G Rabkin; G J Wagner; R Rabkin
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

3.  Alprazolam-ritonavir interaction: implications for product labeling.

Authors:  D J Greenblatt; L L von Moltke; J S Harmatz; A L Durol; J P Daily; J A Graf; P Mertzanis; J L Hoffman; R I Shader
Journal:  Clin Pharmacol Ther       Date:  2000-04       Impact factor: 6.875

4.  Interaction of sildenafil and indinavir when co-administered to HIV-positive patients.

Authors:  C Merry; M G Barry; M Ryan; J F Tjia; M Hennessy; V A Eagling; F Mulcahy; D J Back
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

5.  Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: a pilot study.

Authors:  J A Schwartz; J S McDaniel
Journal:  Depress Anxiety       Date:  1999       Impact factor: 6.505

Review 6.  The use of valproic acid in HIV-positive patients.

Authors:  H R Jennings; F Romanelli
Journal:  Ann Pharmacother       Date:  1999-10       Impact factor: 3.154

7.  Interaction of methadone with didanosine and stavudine.

Authors:  P M Rainey; G Friedland; E F McCance-Katz; L Andrews; S M Mitchell; C Charles; P Jatlow
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

8.  Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.

Authors:  A J Elliott; K K Uldall; K Bergam; J Russo; K Claypoole; P P Roy-Byrne
Journal:  Am J Psychiatry       Date:  1998-03       Impact factor: 18.112

9.  A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.

Authors:  W Breitbart; B Rosenfeld; M Kaim; J Funesti-Esch
Journal:  Arch Intern Med       Date:  2001-02-12

10.  Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.

Authors:  J G Rabkin; G Wagner; R Rabkin
Journal:  J Clin Psychiatry       Date:  1994-10       Impact factor: 4.384
View more
  15 in total

1.  Antidepressant treatment and adherence to antiretroviral medications among privately insured persons with HIV/AIDS.

Authors:  Ayse Akincigil; Ira B Wilson; James T Walkup; Michele J Siegel; Cecilia Huang; Stephen Crystal
Journal:  AIDS Behav       Date:  2011-11

Review 2.  [Clinical features, diagnosis and treatment of HIV-induced neuropsychiatric disorders].

Authors:  Hans-Bernd Rothenhäusler
Journal:  Wien Med Wochenschr       Date:  2006-12

3.  In-home mental health treatment for individuals with HIV.

Authors:  Susan S Reif; Brian W Pence; Sara LeGrand; Elena S Wilson; Marvin Swartz; Terry Ellington; Kathryn Whetten
Journal:  AIDS Patient Care STDS       Date:  2012-10-10       Impact factor: 5.078

4.  Human immunodeficiency virus and depression in primary care: a clinical review.

Authors:  Tiziano Colibazzi; Teresa T Hsu; William S Gilmer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

5.  Effectiveness of antidepressants and predictors of treatment response for depressed HIV patients in Uganda.

Authors:  Victoria K Ngo; Glenn J Wagner; Noeline Nakasujja; Akena Dickens; Frances Aunon; Seggane Musisi
Journal:  Int J STD AIDS       Date:  2014-12-18       Impact factor: 1.359

6.  Impact of antidepressant therapy on cognitive aspects of work, condom use, and psychosocial well-being among HIV clients in Uganda.

Authors:  Glenn J Wagner; Victoria K Ngo; Noeline Nakasujja; Dickens Akena; Frances Aunon; Seggane Musisi
Journal:  Int J Psychiatry Med       Date:  2014       Impact factor: 1.210

7.  Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction.

Authors:  Matthew J Geraci; Stacey L McCoy; Paul M Crum; Rajnikant A Patel
Journal:  Int J Emerg Med       Date:  2010-05-26

8.  A qualitative analysis of the effects of depression and antidepressants on physical and work functioning among antiretroviral therapy clients in Uganda.

Authors:  Victoria K Ngo; Glenn J Wagner; Alexis Huynh; Gery Ryan; Seggane Musisi
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-02-26

Review 9.  HIV and depression: 2008 review and update.

Authors:  Judith G Rabkin
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

10.  Sex differences in benzodiazepine use in the HIV-infected population.

Authors:  Sarah E Wixson; Emily S Brouwer
Journal:  AIDS Care       Date:  2014-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.